| P2093 | author name string | Annalen Bleckmann | |
| | Walter Birchmeier | |
| | Maria Wiese | |
| | Christina Perske | |
| | Felix H Brembeck | |
| | Nathalie Zatula | |
| | Jens Bunzendahl | |
| P2860 | cites work | Wnt/wingless signaling requires BCL9/legless-mediated recruitment of pygopus to the nuclear beta-catenin-TCF complex | Q24294443 |
| | Wnt/beta-catenin and estrogen signaling converge in vivo | Q24300941 |
| | TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes | Q24538709 |
| | Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions | Q24561624 |
| | JASPAR, the open access database of transcription factor-binding profiles: new content and tools in the 2008 update | Q24650787 |
| | Wnt/β-catenin signaling and disease | Q26823272 |
| | Sp1 is essential for estrogen receptor alpha gene transcription | Q38361081 |
| | Epithelial-mesenchymal transition in breast cancer correlates with high histological grade and triple-negative phenotype. | Q39375411 |
| | A transcriptional enhancer required for the differential expression of the human estrogen receptor in breast cancers | Q40021069 |
| | Murine glypican-4 gene structure and expression; Sp1 and Sp3 play a major role in glypican-4 expression in 3T3-F442A cells | Q40528114 |
| | Keratin 19 expression in the adult and developing human mammary gland | Q41138370 |
| | Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice | Q41400379 |
| | A non-canonical DNA structure is a binding motif for the transcription factor SP1 in vitro. | Q41578212 |
| | The estrogen receptor gene: promoter organization and expression | Q41756430 |
| | Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade | Q42510471 |
| | Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype | Q44576030 |
| | Regulation of the estrogen receptor alpha minimal promoter by Sp1, USF-1 and ERalpha | Q44866187 |
| | A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. | Q45749896 |
| | The lack of effect of phenol red or estradiol on the growth response of human, rat, and mouse mammary cells in primary culture | Q46137743 |
| | Pygopus and Legless target Armadillo/beta-catenin to the nucleus to enable its transcriptional co-activator function | Q47315034 |
| | Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform | Q48066328 |
| | BCL9-2 promotes early stages of intestinal tumor progression. | Q52894492 |
| | Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers. | Q53336607 |
| | CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions | Q77755081 |
| | The many faces and functions of β-catenin | Q26865781 |
| | Minireview: genomic organization of the human ERalpha gene promoter region | Q28208469 |
| | Balancing cell adhesion and Wnt signaling, the key role of beta-catenin | Q28288763 |
| | Bcl9/Bcl9l are critical for Wnt-mediated regulation of stem cell traits in colon epithelium and adenocarcinomas | Q28591317 |
| | Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome | Q29616165 |
| | A putative human breast stem cell population is enriched for steroid receptor-positive cells | Q33210333 |
| | The function of BCL9 in Wnt/beta-catenin signaling and colorectal cancer cells | Q33351758 |
| | Genetic mechanisms in Apc-mediated mammary tumorigenesis | Q33406237 |
| | A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis | Q33478377 |
| | Activation of beta -catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. | Q33897191 |
| | Molecular and cellular determinants of estrogen receptor alpha expression | Q34181207 |
| | Key signaling nodes in mammary gland development and cancer: β-catenin | Q34613461 |
| | Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. | Q34712217 |
| | Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells | Q34792452 |
| | Transcriptional regulation of estrogen receptor-alpha by p53 in human breast cancer cells | Q34814407 |
| | The changing role of pathology in breast cancer diagnosis and treatment | Q35082260 |
| | Novel patterns of genome rearrangement and their association with survival in breast cancer | Q35173695 |
| | P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesis | Q35455993 |
| | Genetically engineered mouse models of mammary intraepithelial neoplasia | Q35671166 |
| | Mouse models of estrogen receptor-positive breast cancer | Q35685892 |
| | Wnt proteins in mammary development and cancer | Q35858238 |
| | Sp transcription factor family and its role in cancer | Q36279169 |
| | Information networks in the mammary gland. | Q36289108 |
| | ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias | Q36565533 |
| | WNT10B/β-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer | Q36602135 |
| | Wnt/beta-catenin signaling in cancer stemness and malignant behavior | Q36738603 |
| | Estrogen-related cancer microenvironment of breast carcinoma | Q37170662 |
| | Mammary involution and breast cancer risk: transgenic models and clinical studies | Q37220983 |
| | Chromatin effector Pygo2 regulates mammary tumor initiation and heterogeneity in MMTV-Wnt1 mice | Q37553149 |
| | Mechanisms of estrogen receptor-α upregulation in breast cancers | Q37832430 |
| | Wnt signalling in murine postnatal mammary gland development. | Q37868761 |
| | The different roles of ER subtypes in cancer biology and therapy | Q37903655 |
| | Role of cancer-associated fibroblasts in breast cancer development and prognosis | Q37967584 |
| | 'Cancer associated fibroblasts'--more than meets the eye. | Q38114651 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 16 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 6770-6787 | |
| P577 | publication date | 2014-08-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | The BCL9-2 proto-oncogene governs estrogen receptor alpha expression in breast tumorigenesis | |
| P478 | volume | 5 | |